[CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma

PHASE2UnknownINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 2018

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2025

Conditions
Primary CNS Lymphoma
Interventions
DRUG

Rituximab

500 mg/m2 + 5%DW 500 mL IVF Begin with 50 mg/hr (increase by 50 mg/hr per 30 min until 400 mg/hr is reached)

DRUG

Methotrexate

500 mg/m2 + 5%DW 200 mL IV over 15 minutes 3000 mg/m2 + 5%DW 500 mL IVF over 3 hrs Concurrent hydration and subsequent leucovorin rescue is mandatory

DRUG

Cytarabine Injection

3000 mg/m2 + 5%DW 200 mL IVF over 2 hrs steroid eye drop 0.1%, 2 drops q 6hrs, on days 1-9

Trial Locations (1)

06351

RECRUITING

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Celltrion

INDUSTRY

lead

Won Seog Kim

OTHER